VanEck Biotech ETF
BBH
#1890
ETF rank
โ‚น35.60 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
โ‚น18,107
Share price
0.23%
Change (1 day)
42.11%
Change (1 year)

Expense ratio and fees for VanEck Biotech ETF (BBH)

Expense Ratio

Expense Ratio as of May 2025: 0.35%

Gross Expense Ratio

Gross Expense Ratio as of April 2026: 0.35%

Net Expense Ratio

Net Expense Ratio as of April 2026: 0.35%